Global Pharmacokinetics Software Market Research Report 2026

Industry: Service & Software

Published: 2026-02-11

Pages: 116 Pages

Report ld: 5946955

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description

The global Pharmacokinetics Software market was valued at US$ 529 million in 2025 and is anticipated to reach US$ 909 million by 2032, at a CAGR of 8.2% from 2026 to 2032.

Pharmacokinetics Software is a type of professional software developed based on pharmacokinetic theory and computer algorithms. It is specifically used to process data related to the absorption, distribution, metabolism and excretion of drugs in organisms, and to realize functions such as parameter calculation, model building and process simulation. It provides data support and decision-making basis for drug development, clinical trials and personalized medicine.

Pharmacokinetics Software Market Size(US$)

M= millions and B=billions

North America still dominates the global market, but the Asia-Pacific market is emerging at a faster growth rate. In 2023, North America was the largest revenue market in the field of pharmacokinetic computational biology, and in the life sciences software market, North America accounted for 42% of the market share in 2024, thanks to its mature innovative drug development system and the strong demand from numerous CRO companies.

Policy adjustments by global regulatory agencies are continuously reshaping the development direction of pharmacokinetic software. The FDA's updated guidance in 2023 explicitly requires innovative drug applications to include physiologically based pharmacokinetic (PBPK) model data, and the EMA plans to implement an electronic submission system for ePK files by 2026. These policies are compelling pharmaceutical companies to adopt software with stronger compliance and better data management capabilities.

This report delivers a comprehensive overview of the global Pharmacokinetics Software market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Pharmacokinetics Software. The Pharmacokinetics Software market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Pharmacokinetics Software market comprehensively. Regional market sizes by Type, by Application, by Scene, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Pharmacokinetics Software manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Report Metric
Details
Report Title
Global Pharmacokinetics Software Market Research Report 2026
Forecasted Market Size in 2032
US$ 909 million
CAGR(2026-2032)
8.2%
Market Size Available for Years
2026-2032
Global Pharmacokinetics Software Companies Covered
Certara
Simulations Plus
IntiQuan GmbH
Bayer
Genedata AG
Thermo Scientific
SGS
Pharmaron
Pumas-AI
PharmoGo
Chuangteng Technology
Medixi Biomedical
Global Pharmacokinetics Software Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pharmacokinetics Software Market, Segment by Type
Compartmental Model
Non-Compartmental Models
Global Pharmacokinetics Software Market, Segment by Application
Experimental Design
Clinical Pharmacokinetics
Other
Product Category
Drug Development
Clinical
Academic Teaching
Market Segment
Cloud-Based
On-premises
Forecast Units
Million USD
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Scene, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Pharmacokinetics Software companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

Table of Contents

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Pharmacokinetics Software Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
        1.2.2 Compartmental Model
        1.2.3 Non-Compartmental Models
    1.3 Market by Scene
        1.3.1 Global Pharmacokinetics Software Market Size Growth Rate by Scene: 2021 vs 2025 vs 2032
        1.3.2 Drug Development
        1.3.3 Clinical
        1.3.4 Academic Teaching
    1.4 Market by Deployment
        1.4.1 Global Pharmacokinetics Software Market Size Growth Rate by Deployment: 2021 vs 2025 vs 2032
        1.4.2 Cloud-Based
        1.4.3 On-premises
    1.5 Market by Application
        1.5.1 Global Pharmacokinetics Software Market Growth by Application: 2021 vs 2025 vs 2032
        1.5.2 Experimental Design
        1.5.3 Clinical Pharmacokinetics
        1.5.4 Other
    1.6 Assumptions and Limitations
    1.7 Study Objectives
    1.8 Years Considered

2 Global Growth Trends
    2.1 Global Pharmacokinetics Software Market Perspective (2021–2032)
    2.2 Global Pharmacokinetics Software Growth Trends by Region
        2.2.1 Global Pharmacokinetics Software Market Size by Region: 2021 vs 2025 vs 2032
        2.2.2 Pharmacokinetics Software Historic Market Size by Region (2021–2026)
        2.2.3 Pharmacokinetics Software Forecasted Market Size by Region (2027–2032)
    2.3 Pharmacokinetics Software Market Dynamics
        2.3.1 Pharmacokinetics Software Industry Trends
        2.3.2 Pharmacokinetics Software Market Drivers
        2.3.3 Pharmacokinetics Software Market Challenges
        2.3.4 Pharmacokinetics Software Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Pharmacokinetics Software Players by Revenue
        3.1.1 Global Top Pharmacokinetics Software Players by Revenue (2021–2026)
        3.1.2 Global Pharmacokinetics Software Revenue Market Share by Players (2021–2026)
    3.2 Global Top Pharmacokinetics Software Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
    3.3 Global Key Players Ranking by Pharmacokinetics Software Revenue
    3.4 Global Pharmacokinetics Software Market Concentration Ratio
        3.4.1 Global Pharmacokinetics Software Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Pharmacokinetics Software Revenue in 2025
    3.5 Global Key Players of Pharmacokinetics Software Head Offices and Areas Served
    3.6 Global Key Players of Pharmacokinetics Software, Products and Applications
    3.7 Global Key Players of Pharmacokinetics Software, Date of General Availability (GA)
    3.8 Mergers and Acquisitions, Expansion Plans

4 Pharmacokinetics Software Breakdown Data by Type
    4.1 Global Pharmacokinetics Software Historic Market Size by Type (2021–2026)
    4.2 Global Pharmacokinetics Software Forecasted Market Size by Type (2027–2032)

5 Pharmacokinetics Software Breakdown Data by Application
    5.1 Global Pharmacokinetics Software Historic Market Size by Application (2021–2026)
    5.2 Global Pharmacokinetics Software Forecasted Market Size by Application (2027–2032)

6 North America
    6.1 North America Pharmacokinetics Software Market Size (2021–2032)
    6.2 North America Pharmacokinetics Software Market Growth Rate by Country: 2021 vs 2025 vs 2032
    6.3 North America Pharmacokinetics Software Market Size by Country (2021–2026)
    6.4 North America Pharmacokinetics Software Market Size by Country (2027–2032)
    6.5 United States
    6.6 Canada

7 Europe
    7.1 Europe Pharmacokinetics Software Market Size (2021–2032)
    7.2 Europe Pharmacokinetics Software Market Growth Rate by Country: 2021 vs 2025 vs 2032
    7.3 Europe Pharmacokinetics Software Market Size by Country (2021–2026)
    7.4 Europe Pharmacokinetics Software Market Size by Country (2027–2032)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Ireland

8 Asia-Pacific
    8.1 Asia-Pacific Pharmacokinetics Software Market Size (2021–2032)
    8.2 Asia-Pacific Pharmacokinetics Software Market Growth Rate by Region: 2021 vs 2025 vs 2032
    8.3 Asia-Pacific Pharmacokinetics Software Market Size by Region (2021–2026)
    8.4 Asia-Pacific Pharmacokinetics Software Market Size by Region (2027–2032)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia & New Zealand

9 Latin America
    9.1 Latin America Pharmacokinetics Software Market Size (2021–2032)
    9.2 Latin America Pharmacokinetics Software Market Growth Rate by Country: 2021 vs 2025 vs 2032
    9.3 Latin America Pharmacokinetics Software Market Size by Country (2021–2026)
    9.4 Latin America Pharmacokinetics Software Market Size by Country (2027–2032)
    9.5 Mexico
    9.6 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Pharmacokinetics Software Market Size (2021–2032)
    10.2 Middle East & Africa Pharmacokinetics Software Market Growth Rate by Country: 2021 vs 2025 vs 2032
    10.3 Middle East & Africa Pharmacokinetics Software Market Size by Country (2021–2026)
    10.4 Middle East & Africa Pharmacokinetics Software Market Size by Country (2027–2032)
    10.5 Israel
    10.6 Saudi Arabia
    10.7 UAE

11 Key Players Profiles
    11.1 Certara
        11.1.1 Certara Company Details
        11.1.2 Certara Business Overview
        11.1.3 Certara Pharmacokinetics Software Introduction
        11.1.4 Certara Revenue in Pharmacokinetics Software Business (2021–2026)
        11.1.5 Certara Recent Development
    11.2 Simulations Plus
        11.2.1 Simulations Plus Company Details
        11.2.2 Simulations Plus Business Overview
        11.2.3 Simulations Plus Pharmacokinetics Software Introduction
        11.2.4 Simulations Plus Revenue in Pharmacokinetics Software Business (2021–2026)
        11.2.5 Simulations Plus Recent Development
    11.3 IntiQuan GmbH
        11.3.1 IntiQuan GmbH Company Details
        11.3.2 IntiQuan GmbH Business Overview
        11.3.3 IntiQuan GmbH Pharmacokinetics Software Introduction
        11.3.4 IntiQuan GmbH Revenue in Pharmacokinetics Software Business (2021–2026)
        11.3.5 IntiQuan GmbH Recent Development
    11.4 Bayer
        11.4.1 Bayer Company Details
        11.4.2 Bayer Business Overview
        11.4.3 Bayer Pharmacokinetics Software Introduction
        11.4.4 Bayer Revenue in Pharmacokinetics Software Business (2021–2026)
        11.4.5 Bayer Recent Development
    11.5 Genedata AG
        11.5.1 Genedata AG Company Details
        11.5.2 Genedata AG Business Overview
        11.5.3 Genedata AG Pharmacokinetics Software Introduction
        11.5.4 Genedata AG Revenue in Pharmacokinetics Software Business (2021–2026)
        11.5.5 Genedata AG Recent Development
    11.6 Thermo Scientific
        11.6.1 Thermo Scientific Company Details
        11.6.2 Thermo Scientific Business Overview
        11.6.3 Thermo Scientific Pharmacokinetics Software Introduction
        11.6.4 Thermo Scientific Revenue in Pharmacokinetics Software Business (2021–2026)
        11.6.5 Thermo Scientific Recent Development
    11.7 SGS
        11.7.1 SGS Company Details
        11.7.2 SGS Business Overview
        11.7.3 SGS Pharmacokinetics Software Introduction
        11.7.4 SGS Revenue in Pharmacokinetics Software Business (2021–2026)
        11.7.5 SGS Recent Development
    11.8 Pharmaron
        11.8.1 Pharmaron Company Details
        11.8.2 Pharmaron Business Overview
        11.8.3 Pharmaron Pharmacokinetics Software Introduction
        11.8.4 Pharmaron Revenue in Pharmacokinetics Software Business (2021–2026)
        11.8.5 Pharmaron Recent Development
    11.9 Pumas-AI
        11.9.1 Pumas-AI Company Details
        11.9.2 Pumas-AI Business Overview
        11.9.3 Pumas-AI Pharmacokinetics Software Introduction
        11.9.4 Pumas-AI Revenue in Pharmacokinetics Software Business (2021–2026)
        11.9.5 Pumas-AI Recent Development
    11.10 PharmoGo
        11.10.1 PharmoGo Company Details
        11.10.2 PharmoGo Business Overview
        11.10.3 PharmoGo Pharmacokinetics Software Introduction
        11.10.4 PharmoGo Revenue in Pharmacokinetics Software Business (2021–2026)
        11.10.5 PharmoGo Recent Development
    11.11 Chuangteng Technology
        11.11.1 Chuangteng Technology Company Details
        11.11.2 Chuangteng Technology Business Overview
        11.11.3 Chuangteng Technology Pharmacokinetics Software Introduction
        11.11.4 Chuangteng Technology Revenue in Pharmacokinetics Software Business (2021–2026)
        11.11.5 Chuangteng Technology Recent Development
    11.12 Medixi Biomedical
        11.12.1 Medixi Biomedical Company Details
        11.12.2 Medixi Biomedical Business Overview
        11.12.3 Medixi Biomedical Pharmacokinetics Software Introduction
        11.12.4 Medixi Biomedical Revenue in Pharmacokinetics Software Business (2021–2026)
        11.12.5 Medixi Biomedical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
            13.1.1.1 Research Programs/Design
            13.1.1.2 Market Size Estimation
            13.1.1.3 Market Breakdown and Data Triangulation
        13.1.2 Data Source
            13.1.2.1 Secondary Sources
            13.1.2.2 Primary Sources
    13.2 Author Details
    13.3 Disclaimer

Table of Figures

List of Tables
Table 1. Global Pharmacokinetics Software Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Compartmental Model
Table 3. Key Players of Non-Compartmental Models
Table 4. Global Pharmacokinetics Software Market Size Growth Rate by Scene (US$ Million): 2021 vs 2025 vs 2032
Table 5. Key Players of Drug Development
Table 6. Key Players of Clinical
Table 7. Key Players of Academic Teaching
Table 8. Global Pharmacokinetics Software Market Size Growth Rate by Deployment (US$ Million): 2021 vs 2025 vs 2032
Table 9. Key Players of Cloud-Based
Table 10. Key Players of On-premises
Table 11. Global Pharmacokinetics Software Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 12. Global Pharmacokinetics Software Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 13. Global Pharmacokinetics Software Market Size by Region (US$ Million), 2021–2026
Table 14. Global Pharmacokinetics Software Market Share by Region (2021–2026)
Table 15. Global Pharmacokinetics Software Forecasted Market Size by Region (US$ Million), 2027–2032
Table 16. Global Pharmacokinetics Software Market Share by Region (2027–2032)
Table 17. Pharmacokinetics Software Market Trends
Table 18. Pharmacokinetics Software Market Drivers
Table 19. Pharmacokinetics Software Market Challenges
Table 20. Pharmacokinetics Software Market Restraints
Table 21. Global Pharmacokinetics Software Revenue by Players (US$ Million), 2021–2026
Table 22. Global Pharmacokinetics Software Market Share by Players (2021–2026)
Table 23. Global Top Pharmacokinetics Software Players by Tier (Tier 1, Tier 2, and Tier 3), based on Pharmacokinetics Software Revenue, 2025
Table 24. Ranking of Global Top Pharmacokinetics Software Companies by Revenue (US$ Million) in 2025
Table 25. Global 5 Largest Players Market Share by Pharmacokinetics Software Revenue (CR5 and HHI), 2021–2026
Table 26. Global Key Players of Pharmacokinetics Software, Headquarters and Area Served
Table 27. Global Key Players of Pharmacokinetics Software, Products and Applications
Table 28. Global Key Players of Pharmacokinetics Software, Date of General Availability (GA)
Table 29. Mergers and Acquisitions, Expansion Plans
Table 30. Global Pharmacokinetics Software Market Size by Type (US$ Million), 2021–2026
Table 31. Global Pharmacokinetics Software Revenue Market Share by Type (2021–2026)
Table 32. Global Pharmacokinetics Software Forecasted Market Size by Type (US$ Million), 2027–2032
Table 33. Global Pharmacokinetics Software Revenue Market Share by Type (2027–2032)
Table 34. Global Pharmacokinetics Software Market Size by Application (US$ Million), 2021–2026
Table 35. Global Pharmacokinetics Software Revenue Market Share by Application (2021–2026)
Table 36. Global Pharmacokinetics Software Forecasted Market Size by Application (US$ Million), 2027–2032
Table 37. Global Pharmacokinetics Software Revenue Market Share by Application (2027–2032)
Table 38. North America Pharmacokinetics Software Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 39. North America Pharmacokinetics Software Market Size by Country (US$ Million), 2021–2026
Table 40. North America Pharmacokinetics Software Market Size by Country (US$ Million), 2027–2032
Table 41. Europe Pharmacokinetics Software Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Europe Pharmacokinetics Software Market Size by Country (US$ Million), 2021–2026
Table 43. Europe Pharmacokinetics Software Market Size by Country (US$ Million), 2027–2032
Table 44. Asia-Pacific Pharmacokinetics Software Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 45. Asia-Pacific Pharmacokinetics Software Market Size by Region (US$ Million), 2021–2026
Table 46. Asia-Pacific Pharmacokinetics Software Market Size by Region (US$ Million), 2027–2032
Table 47. Latin America Pharmacokinetics Software Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 48. Latin America Pharmacokinetics Software Market Size by Country (US$ Million), 2021–2026
Table 49. Latin America Pharmacokinetics Software Market Size by Country (US$ Million), 2027–2032
Table 50. Middle East & Africa Pharmacokinetics Software Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 51. Middle East & Africa Pharmacokinetics Software Market Size by Country (US$ Million), 2021–2026
Table 52. Middle East & Africa Pharmacokinetics Software Market Size by Country (US$ Million), 2027–2032
Table 53. Certara Company Details
Table 54. Certara Business Overview
Table 55. Certara Pharmacokinetics Software Product
Table 56. Certara Revenue in Pharmacokinetics Software Business (US$ Million), 2021–2026
Table 57. Certara Recent Development
Table 58. Simulations Plus Company Details
Table 59. Simulations Plus Business Overview
Table 60. Simulations Plus Pharmacokinetics Software Product
Table 61. Simulations Plus Revenue in Pharmacokinetics Software Business (US$ Million), 2021–2026
Table 62. Simulations Plus Recent Development
Table 63. IntiQuan GmbH Company Details
Table 64. IntiQuan GmbH Business Overview
Table 65. IntiQuan GmbH Pharmacokinetics Software Product
Table 66. IntiQuan GmbH Revenue in Pharmacokinetics Software Business (US$ Million), 2021–2026
Table 67. IntiQuan GmbH Recent Development
Table 68. Bayer Company Details
Table 69. Bayer Business Overview
Table 70. Bayer Pharmacokinetics Software Product
Table 71. Bayer Revenue in Pharmacokinetics Software Business (US$ Million), 2021–2026
Table 72. Bayer Recent Development
Table 73. Genedata AG Company Details
Table 74. Genedata AG Business Overview
Table 75. Genedata AG Pharmacokinetics Software Product
Table 76. Genedata AG Revenue in Pharmacokinetics Software Business (US$ Million), 2021–2026
Table 77. Genedata AG Recent Development
Table 78. Thermo Scientific Company Details
Table 79. Thermo Scientific Business Overview
Table 80. Thermo Scientific Pharmacokinetics Software Product
Table 81. Thermo Scientific Revenue in Pharmacokinetics Software Business (US$ Million), 2021–2026
Table 82. Thermo Scientific Recent Development
Table 83. SGS Company Details
Table 84. SGS Business Overview
Table 85. SGS Pharmacokinetics Software Product
Table 86. SGS Revenue in Pharmacokinetics Software Business (US$ Million), 2021–2026
Table 87. SGS Recent Development
Table 88. Pharmaron Company Details
Table 89. Pharmaron Business Overview
Table 90. Pharmaron Pharmacokinetics Software Product
Table 91. Pharmaron Revenue in Pharmacokinetics Software Business (US$ Million), 2021–2026
Table 92. Pharmaron Recent Development
Table 93. Pumas-AI Company Details
Table 94. Pumas-AI Business Overview
Table 95. Pumas-AI Pharmacokinetics Software Product
Table 96. Pumas-AI Revenue in Pharmacokinetics Software Business (US$ Million), 2021–2026
Table 97. Pumas-AI Recent Development
Table 98. PharmoGo Company Details
Table 99. PharmoGo Business Overview
Table 100. PharmoGo Pharmacokinetics Software Product
Table 101. PharmoGo Revenue in Pharmacokinetics Software Business (US$ Million), 2021–2026
Table 102. PharmoGo Recent Development
Table 103. Chuangteng Technology Company Details
Table 104. Chuangteng Technology Business Overview
Table 105. Chuangteng Technology Pharmacokinetics Software Product
Table 106. Chuangteng Technology Revenue in Pharmacokinetics Software Business (US$ Million), 2021–2026
Table 107. Chuangteng Technology Recent Development
Table 108. Medixi Biomedical Company Details
Table 109. Medixi Biomedical Business Overview
Table 110. Medixi Biomedical Pharmacokinetics Software Product
Table 111. Medixi Biomedical Revenue in Pharmacokinetics Software Business (US$ Million), 2021–2026
Table 112. Medixi Biomedical Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
Table 116. Authors List of This Report

List of Figures
Figure 1. Pharmacokinetics Software Picture
Figure 2. Global Pharmacokinetics Software Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Pharmacokinetics Software Market Share by Type: 2025 vs 2032
Figure 4. Compartmental Model Features
Figure 5. Non-Compartmental Models Features
Figure 6. Global Pharmacokinetics Software Market Size Comparison by Scene (US$ Million), 2021–2032
Figure 7. Drug Development Features
Figure 8. Clinical Features
Figure 9. Academic Teaching Features
Figure 10. Global Pharmacokinetics Software Market Size Comparison by Deployment (US$ Million), 2021–2032
Figure 11. Cloud-Based Features
Figure 12. On-premises Features
Figure 13. Global Pharmacokinetics Software Market Size by Application (US$ Million), 2021–2032
Figure 14. Global Pharmacokinetics Software Market Share by Application: 2025 vs 2032
Figure 15. Experimental Design Case Studies
Figure 16. Clinical Pharmacokinetics Case Studies
Figure 17. Other Case Studies
Figure 18. Pharmacokinetics Software Report Years Considered
Figure 19. Global Pharmacokinetics Software Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 20. Global Pharmacokinetics Software Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 21. Global Pharmacokinetics Software Market Share by Region: 2025 vs 2032
Figure 22. Global Pharmacokinetics Software Market Share by Players in 2025
Figure 23. Global Pharmacokinetics Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 24. The Top 10 and 5 Players Market Share by Pharmacokinetics Software Revenue in 2025
Figure 25. North America Pharmacokinetics Software Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. North America Pharmacokinetics Software Market Share by Country (2021–2032)
Figure 27. United States Pharmacokinetics Software Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Canada Pharmacokinetics Software Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Europe Pharmacokinetics Software Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Europe Pharmacokinetics Software Market Share by Country (2021–2032)
Figure 31. Germany Pharmacokinetics Software Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. France Pharmacokinetics Software Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. U.K. Pharmacokinetics Software Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Italy Pharmacokinetics Software Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Russia Pharmacokinetics Software Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Ireland Pharmacokinetics Software Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Asia-Pacific Pharmacokinetics Software Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Asia-Pacific Pharmacokinetics Software Market Share by Region (2021–2032)
Figure 39. China Pharmacokinetics Software Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Japan Pharmacokinetics Software Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. South Korea Pharmacokinetics Software Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Southeast Asia Pharmacokinetics Software Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. India Pharmacokinetics Software Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Australia & New Zealand Pharmacokinetics Software Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Latin America Pharmacokinetics Software Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Latin America Pharmacokinetics Software Market Share by Country (2021–2032)
Figure 47. Mexico Pharmacokinetics Software Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Brazil Pharmacokinetics Software Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Middle East & Africa Pharmacokinetics Software Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. Middle East & Africa Pharmacokinetics Software Market Share by Country (2021–2032)
Figure 51. Israel Pharmacokinetics Software Market Size YoY Growth (US$ Million), 2021–2032
Figure 52. Saudi Arabia Pharmacokinetics Software Market Size YoY Growth (US$ Million), 2021–2032
Figure 53. UAE Pharmacokinetics Software Market Size YoY Growth (US$ Million), 2021–2032
Figure 54. Certara Revenue Growth Rate in Pharmacokinetics Software Business (2021–2026)
Figure 55. Simulations Plus Revenue Growth Rate in Pharmacokinetics Software Business (2021–2026)
Figure 56. IntiQuan GmbH Revenue Growth Rate in Pharmacokinetics Software Business (2021–2026)
Figure 57. Bayer Revenue Growth Rate in Pharmacokinetics Software Business (2021–2026)
Figure 58. Genedata AG Revenue Growth Rate in Pharmacokinetics Software Business (2021–2026)
Figure 59. Thermo Scientific Revenue Growth Rate in Pharmacokinetics Software Business (2021–2026)
Figure 60. SGS Revenue Growth Rate in Pharmacokinetics Software Business (2021–2026)
Figure 61. Pharmaron Revenue Growth Rate in Pharmacokinetics Software Business (2021–2026)
Figure 62. Pumas-AI Revenue Growth Rate in Pharmacokinetics Software Business (2021–2026)
Figure 63. PharmoGo Revenue Growth Rate in Pharmacokinetics Software Business (2021–2026)
Figure 64. Chuangteng Technology Revenue Growth Rate in Pharmacokinetics Software Business (2021–2026)
Figure 65. Medixi Biomedical Revenue Growth Rate in Pharmacokinetics Software Business (2021–2026)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

Description

The global Pharmacokinetics Software market was valued at US$ 529 million in 2025 and is anticipated to reach US$ 909 million by 2032, at a CAGR of 8.2% from 2026 to 2032.

Pharmacokinetics Software is a type of professional software developed based on pharmacokinetic theory and computer algorithms. It is specifically used to process data related to the absorption, distribution, metabolism and excretion of drugs in organisms, and to realize functions such as parameter calculation, model building and process simulation. It provides data support and decision-making basis for drug development, clinical trials and personalized medicine.

Market Segmentation

Related Reports

Global Pharmacokinetics Software Market Research Report 2024
The global Pharmacokinetics Software market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-18
Pages: 85
USD 2900.00
(Single User License)
Global Pharmacokinetics Software Market Insights, Forecast to 2030
Market Analysis and Insights: Global Pharmacokinetics Software Market
Published: 2024-04-26
Pages: 112
USD 4900.00
(Single User License)
Global Pharmacokinetics Software Market Research Report 2025
The global market for Pharmacokinetics Software was valued at US$ 476 million in the year 2024 and is projected to reach a revised size of US$ 846 million by 2031, growing at a CAGR of 8.2% during the forecast period.
Published: 2025-11-27
Pages: 84
USD 2900.00
(Single User License)
Pharmacokinetics Software- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharmacokinetics Software was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-03
Pages: 106
USD 3950.00
(Single User License)
Global Pharmacokinetics Software Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pharmacokinetics Software market size was US$ 476 million in 2024 and is forecast to a readjusted size of US$ 846 million by 2031 with a CAGR of 8.2% during the forecast period 2025-2031.
Published: 2025-11-27
Pages: 93
USD 4250.00
(Single User License)
Global Pharmacokinetics Software Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Pharmacokinetics Software market is projected to grow from US$ 476 million in 2024 to US$ 846 million by 2031, at a CAGR of 8.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-11-27
Pages: 143
USD 4900.00
(Single User License)
Pharmacokinetics Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharmacokinetics Software was estimated to be worth US$ 476 million in 2024 and is forecast to a readjusted size of US$ 846 million by 2031 with a CAGR of 8.2% during the forecast period 2025-2031.
Published: 2025-11-27
Pages: 120
USD 3950.00
(Single User License)
Pharmacokinetics Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pharmacokinetics Software was estimated to be worth US$ 529 million in 2025 and is projected to reach US$ 909 million, growing at a CAGR of 8.2% from 2026 to 2032.
Published: 2026-02-11
Pages: 106
USD 3950.00
(Single User License)

Global Pharmacokinetics Software Market Research Report 2024
The global Pharmacokinetics Software market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-18
Pages: 85
USD 2900.00 ()
Global Pharmacokinetics Software Market Insights, Forecast to 2030
Market Analysis and Insights: Global Pharmacokinetics Software Market
Published: 2024-04-26
Pages: 112
USD 4900.00 ()
Global Pharmacokinetics Software Market Research Report 2025
The global market for Pharmacokinetics Software was valued at US$ 476 million in the year 2024 and is projected to reach a revised size of US$ 846 million by 2031, growing at a CAGR of 8.2% during the forecast period.
Published: 2025-11-27
Pages: 84
USD 2900.00 ()
Pharmacokinetics Software- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharmacokinetics Software was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-03
Pages: 106
USD 3950.00 ()
Global Pharmacokinetics Software Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pharmacokinetics Software market size was US$ 476 million in 2024 and is forecast to a readjusted size of US$ 846 million by 2031 with a CAGR of 8.2% during the forecast period 2025-2031.
Published: 2025-11-27
Pages: 93
USD 4250.00 ()
Global Pharmacokinetics Software Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Pharmacokinetics Software market is projected to grow from US$ 476 million in 2024 to US$ 846 million by 2031, at a CAGR of 8.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-11-27
Pages: 143
USD 4900.00 ()
Pharmacokinetics Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharmacokinetics Software was estimated to be worth US$ 476 million in 2024 and is forecast to a readjusted size of US$ 846 million by 2031 with a CAGR of 8.2% during the forecast period 2025-2031.
Published: 2025-11-27
Pages: 120
USD 3950.00 ()
Pharmacokinetics Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pharmacokinetics Software was estimated to be worth US$ 529 million in 2025 and is projected to reach US$ 909 million, growing at a CAGR of 8.2% from 2026 to 2032.
Published: 2026-02-11
Pages: 106
USD 3950.00 ()